Journal article · 2020 · Open access

The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders

Samantha Cruz Rivera, Christel McMullan, Laura L. Jones, Derek G. Kyte, Anita L. Slade, Melanie Calvert

Journal of Patient-Reported Outcomes, 4(1), 51 · Published 2 July 2020 · DOI 10.1186/s41687-020-00219-4

Open PDFView at the publisherCite this paper

In brief

“The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders” is a 2020 journal article by Samantha Cruz Rivera and 5 co-authors, published in Journal of Patient-Reported Outcomes. OpenAlex counts 58 citations as of 22 November 2026, which puts it in the top 2% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Patient-Reported Outcomes.

Citations
58
Most cited in
2024 (20)
Field-weighted impact
3.77
References
45
Authors
6

Abstract

BACKGROUND: Patient-reported outcomes (PROs) are increasingly collected in clinical trials as they provide unique information on the physical, functional and psychological impact of a treatment from the patient's perspective. Recent research suggests that PRO trial data have the potential to inform shared decision-making, support pharmaceutical labelling claims and influence healthcare policy and practice. However, there remains limited evidence regarding the actual impact associated with PRO trial data and how to maximise PRO impact to benefit patients and society. Thus, our objective was to qualitatively explore international stakeholders' perspectives surrounding: a) the impact of PRO trial data, b) impact measurement metrics, and c) barriers and facilitators to effectively maximise the impact of PRO trial data upon patients and society. METHODS: Semi-structured interviews with 24 international stakeholders were conducted between May and October 2018. Data were coded and analysed using reflexive thematic analysis. RESULTS: International stakeholders emphasised the impact of PRO trial data to benefit patients and society. Influence on policy-impact, including changes to clinical healthcare practice and guidelines, drug approval and promotional labelling claims were common types of PRO impact reported by interviewees. Interviewees suggested impact measurement metrics including: number of pharmaceutical labelling claims and interviews with healthcare practitioners to determine whether PRO data were incorporated in clinical decision-making. Key facilitators to PRO impact highlighted by stakeholders included: standardisation of PRO tools; consideration of health utilities when selecting PRO measures; adequate funding to support PRO research; improved reporting and dissemination of PRO trial data by key opinion leaders and patients; and development of legal enforcement of the collection of PRO data. CONCLUSIONS: Determining the impact of PRO trial data is essential to better allocate funds, minimise research waste and to help maximise the impact of these data for patients and society. However, measuring the impact of PRO trial data through metrics is a challenging task, as current measures do not capture the total impact of PRO research. Broader international multi-stakeholder engagement and collaboration is needed to standardise PRO assessment and maximise the impact of PRO trial data to benefit patients and society.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rivera, S. C., McMullan, C., Jones, L. L., Kyte, D. G., Slade, A. L., & Calvert, M. (2020). The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders. Journal of Patient-Reported Outcomes, 4(1), 51. https://doi.org/10.1186/s41687-020-00219-4

MLA 9

Rivera, Samantha Cruz, et al. “The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders.” Journal of Patient-Reported Outcomes, vol. 4, no. 1, 2020, p. 51. https://doi.org/10.1186/s41687-020-00219-4.

Chicago

Rivera, Samantha Cruz, Christel McMullan, Laura L. Jones, Derek G. Kyte, Anita L. Slade, and Melanie Calvert. 2020. “The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders.” Journal of Patient-Reported Outcomes 4 (1): 51. https://doi.org/10.1186/s41687-020-00219-4.

Harvard

Rivera, S. C. et al. (2020) ‘The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders’, Journal of Patient-Reported Outcomes, 4(1), p. 51. doi:10.1186/s41687-020-00219-4.

IEEE

S. C. Rivera, C. McMullan, L. L. Jones, D. G. Kyte, A. L. Slade, and M. Calvert, “The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders,” Journal of Patient-Reported Outcomes, vol. 4, no. 1, p. 51, 2020, doi: 10.1186/s41687-020-00219-4.

BibTeX

@article{rivera2020impact,
  title     = {{The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders}},
  author    = {Rivera, Samantha Cruz and McMullan, Christel and Jones, Laura L. and Kyte, Derek G. and Slade, Anita L. and Calvert, Melanie},
  journal   = {Journal of Patient-Reported Outcomes},
  year      = {2020},
  volume    = {4},
  number    = {1},
  pages     = {51},
  doi       = {10.1186/s41687-020-00219-4},
  url       = {https://doi.org/10.1186/s41687-020-00219-4}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20221212
20231010
20242020
202599
202677

Its field-weighted citation impact is 3.77: it has been cited 3.77 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • patient-reported outcomes
  • clinical trials
  • drug approval
  • healthcare policy
  • shared decision-making
  • health utility
  • research waste
  • stakeholder perspectives

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Rivera, S. C., McMullan, C., Jones, L. L., Kyte, D. G., Slade, A. L., & Calvert, M. (2020). The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders. Journal of Patient-Reported Outcomes, 4(1), 51. https://doi.org/10.1186/s41687-020-00219-4

How many times has this paper been cited?

58 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Patient-Reported Outcomes: sign in and open the PDF from this page.

Who wrote this paper?

Samantha Cruz Rivera, Christel McMullan, Laura L. Jones, Derek G. Kyte, Anita L. Slade, Melanie Calvert.

What is the DOI of this paper?

10.1186/s41687-020-00219-4, permanently at https://doi.org/10.1186/s41687-020-00219-4. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.